✦ LIBER ✦

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial

✍ Scribed by Tolosa, Eduardo; HernÃ¡ndez, Basilio; Linazasoro, Gurutz; LÃ³pez-Lozano, Juan JosÃ©; Mir, Pablo; Marey, JosÃ©; Kulisevsky, Jaime

Book ID: 121377186
Publisher: Springer
Year: 2013
Tongue: English
Weight: 445 KB
Volume: 121
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-013-1114-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind trial of levodopa/carbidopa

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

PND37 PATIENT AND PHYSICIAN GLOBAL PERCE

PND37 PATIENT AND PHYSICIAN GLOBAL PERCEPTION OF LEVODOPA/ CARBIDOPA/ENTACAPONE VS. LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE EXPERIENCING EARLY WEARING-OFF

✍ J Ruyra; M Balañá; R Lahoz; B Hernandez; E Tolosa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

P2.092 A randomized, double-blind evalua

P2.092 A randomized, double-blind evaluation of levodopa/carbidopa/entacapone versus immediate-release levodopa/carbidopa in patients with Parkinson's disease exhibiting nonmotor symptoms of wearing off

✍ M. Stacy; K. Mccague; M. Weidenman; A. Campbell; M. Somogyi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Direct switch from levodopa/benserazide

Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study

✍ Karla Eggert; Örjan Skogar; Khaled Amar; Liisa Luotonen; Mikko Kuoppamäki; Mika 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 335 KB

Extended-release carbidopa-levodopa (IPX

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

✍ Hauser, Robert A; Hsu, Ann; Kell, Sherron; Espay, Alberto J; Sethi, Kapil; Stacy 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 233 KB

Immediate Versus Delayed Switch From Lev

Immediate Versus Delayed Switch From Levodopa/Carbidopa to Levodopa/Carbidopa/Entacapone: Effects on Motor Function and Quality of Life in Patients With Parkinson's Disease With End-of-Dose Wearing Off

✍ Lew, Mark F.; Somogyi, Monique; McCague, Kevin; Welsh, Mickie; on behalf of the 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 339 KB